𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Outpatient treatment with subcutaneous interleukin-2, interferon alpha and fluorouracil in patients with metastatic renal cancer: an Australian experience

✍ Scribed by G. Marx; J. Taylor; D. Goldstein

Book ID
109001448
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
77 KB
Volume
35
Category
Article
ISSN
1444-0903

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II trial of intravenous gemcitab
A Phase II trial of intravenous gemcitabine and 5-fluorouracil with subcutaneous interleukin-2 and interferon-α in patients with metastatic renal cell carcinoma
✍ Christopher W. Ryan; Nicholas J. Vogelzang; Walter M. Stadler 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 2 views

## Abstract ## BACKGROUND The objective of this study was to determine the response rate and toxicity of gemcitabine and continuous‐infusion 5‐fluorouracil (5‐FU) in combination with subcutaneous interleukin‐2 (IL2) and interferon‐α (IFNA) in patients with metastatic renal cell carcinoma. ## METH

Induction of tyrosinase-reactive T cells
Induction of tyrosinase-reactive T cells by treatment with dacarbazine, cisplatin, interferon-alpha ± interleukin-2 in patients with metastatic melanoma
✍ Alexander Schmittel; Ulrich Keilholz; Regina Max; Eckhard Thiel; Carmen Scheiben 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 92 KB 👁 2 views

We have shown the presence of tyrosinase-reactive T cells in the peripheral blood of melanoma patients, who had been in remission after treatment with IL-2-containing regimens. In this consecutive study, we analyzed the T-cell response to various peptides derived from tyrosinase in serial blood samp